Literature DB >> 32901366

Correlations between long-term quality of life and patient needs and concerns following head and neck cancer treatment and the impact of psychological distress. A multicentric cross-sectional study.

Roxane Elaldi1, Lise-Marie Roussel2, Jocelyn Gal3, Boris Scheller1, Emmanuel Chamorey3, Renaud Schiappa3, Audrey Lasne-Cardon2, Marie-Yolande Louis2, Dorian Culié1, Olivier Dassonville1, Gilles Poissonnet1, Esma Saada4, Karen Benezery5, Emmanuel Babin6, Alexandre Bozec7.   

Abstract

OBJECTIVES: To assess patient needs and concerns after head and neck squamous cell carcinoma (HNSCC) treatment and their possible correlations with long-term quality of life (QoL) and to examine the potential impact of psychological distress on these results.
METHODS: Alive and disease-free HNSCC patients at least 1 year after treatment were enrolled in this cross-sectional multicentric study and completed the EORTC QLQ-C30 and H&N35 QoL questionnaires, the head and neck cancer-specific patient concerns inventory (PCI-HN) questionnaire and the hospital anxiety and depression scale (HADS). Correlations between QoL outcomes and patient needs and concerns were investigated using Spearman's correlation tests.
RESULTS: Seventy-two patients were enrolled in the study. Fear of cancer recurrence was the main patient concern followed by dental, salivary, fatigue, speech, and eating problems. The leading patient needs in terms of consultation were to be referred to the surgeon, the speech, and swallow therapist and the oral rehabilitation team. The number of patient concerns correlated negatively (r < .40) with functioning scales score and positively (r > .40) with general and head and neck symptoms. Psychological distress was the main determinant of QoL outcomes (p < .0001). We found a significant impact of gender (p = .002) on the number of patient concerns, and of patient age (p = .003) on the number of staff members selected by patients.
CONCLUSION: Identification of patient needs and concerns along with multidisciplinary management of persistent symptoms and psychological distress seem essential steps towards improving QoL of HNSCC patients.

Entities:  

Keywords:  Head and neck cancer; Patient concerns; Patient needs; Psychological distress; Quality of life

Year:  2020        PMID: 32901366     DOI: 10.1007/s00405-020-06326-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  4 in total

1.  Prospective longitudinal study on fear of cancer recurrence in patients newly diagnosed with head and neck cancer: Course, trajectories, and associated factors.

Authors:  Esther Deuning-Smit; José A E Custers; Špela Miroševič; Robert P Takes; Femke Jansen; Johannes A Langendijk; Chris H J Terhaard; Robert J Baatenburg de Jong; C René Leemans; Johannes H Smit; Linda Kwakkenbos; Irma M Verdonck-de Leeuw; Judith B Prins
Journal:  Head Neck       Date:  2022-01-27       Impact factor: 3.821

Review 2.  Open Questions in Cold Atmospheric Plasma Treatment in Head and Neck Cancer: A Systematic Review.

Authors:  Vittoria Perrotti; Vito Carlo Alberto Caponio; Lorenzo Lo Muzio; Eun Ha Choi; Maria Carmela Di Marcantonio; Mariangela Mazzone; Nagendra Kumar Kaushik; Gabriella Mincione
Journal:  Int J Mol Sci       Date:  2022-09-06       Impact factor: 6.208

Review 3.  The Patient Concerns Inventory in head and neck oncology: a structured review of its development, validation and clinical implications.

Authors:  Anastasios Kanatas; Derek Lowe; Simon N Rogers
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-07-17       Impact factor: 3.236

4.  Quality-of-Life Assessment after Head and Neck Oncological Surgery for Advanced-Stage Tumours.

Authors:  Paula Luiza Bejenaru; Bogdan Popescu; Alina Lavinia Antoaneta Oancea; Catrinel Beatrice Simion-Antonie; Gloria Simona Berteșteanu; Mihnea Condeescu-Cojocarița; Anca Ionela Cîrstea; Irina Doinița Oașă; Teodora Elena Schipor-Diaconu; Dan Popescu; Raluca Grigore
Journal:  J Clin Med       Date:  2022-08-19       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.